Skip to main content

Sound Advice: October 29, 2026

It's Medicare "Disadvantage" time again. PLEASE IGNORE 

Medicare Advantage plans are frequently criticized as a bad idea because they replace the open access of Original Medicare with restrictive, managed-care networks and heavy administrative hurdles. While these private insurance plans are heavily marketed for their "$0 premiums" and extra perks like dental or vision care, critics point out that they introduce significant financial and medical risks when you actually become sick.

The primary reasons consumer advocates, medical professionals, and patients consider Medicare Advantage a bad idea center on the following systematic limitations:

1. Restrictive Provider Networks

  • Limited choices: You are confined to a specific network of local doctors and hospitals (HMOs or PPOs).
  • Dropping providers: Insurance companies can drop doctors or entire hospital systems from their network at any time during the year.
  • No travel coverage: If you travel outside your plan's regional service area, you generally have no coverage except for emergency care.

2. Prior Authorizations and Care Denials

  • Gatekeeping: You often must get advance permission (prior authorization) from the insurance company before receiving critical treatments, MRIs or surgeries.
  • Delayed care: This administrative review process can cause dangerous delays while you wait for approval.
  • High denial rates: Healthcare providers note on various social media platforms such as Reddit that Medicare Advantage plans exhibit high claim and care denial rates for specialty care, expensive medications, and inpatient rehabilitation.

3. Financial Exposure and "Pay-As-You-Go" Costs

  • High out-of-pocket maximums: While the monthly premium might be $0, you pay copays or coinsurance every time you see a doctor or get a test. In 2026, the maximum out-of-pocket cap for in-network services is $9,250, meaning a serious illness can result in thousands of dollars in unexpected bills.
  • No Medigap protection: You are legally prohibited from buying a Medigap (Medicare Supplement) policy to cover these out-of-pocket costs if you are on an Advantage plan.

4. The "Medigap Trap"

  • Locked-in status: If you enroll in Medicare Advantage and later get sick, you may want to switch back to Original Medicare to see any doctor you want. Even so, it’s critical to be aware that there are doctors, especially those who are most skilled, who do not accept Medicare.  When you want the very best, you may well have to pay out of pocket.
  • Medical underwriting: In most states, once you are past your initial enrollment period, Medigap insurers can look at your medical history and deny you coverage or charge astronomical premiums for pre-existing conditions. This effectively traps sick beneficiaries in their Advantage plans.

5. Unstable Benefits and Volatile Coverage

  • Annual changes: Unlike Original Medicare, which features highly stable, government-legislated coverage, private Medicare Advantage plans alter their rules, copays, drug formularies, and extra perks every single year.
  • Benefit scaling: Many private insurers are actively scaling back or entirely cutting non-medical "fringe" benefits to protect their profit margins.

  

Comments

Popular posts from this blog

Sound Advice: October 14, 2026

Why your adviser must be a fiduciary   You should insist that your financial adviser be a fiduciary because a fiduciary is legally obligated, when acting in a fiduciary capacity, to put your interests ahead of their own and manage conflicts of interest appropriately. Key reasons: Your interests come first. A fiduciary duty requires the adviser to act in your best interest rather than simply recommending something that is suitable or profitable for them. Fewer conflicts of interest. Some advisers can receive commissions, bonuses, or other compensation for recommending particular investments or insurance products. A fiduciary must address material conflicts rather than allowing them to drive the recommendation. Greater transparency. Fiduciary advisers generally have obligations concerning disclosure, fees, conflicts, and how they are compensated. That makes it easier for you to understand what you're actually paying. Better alignment over the long term. A good adviser sh...

Sound Advice: September 30, 2026

Now what? For many women, there comes a time when financial confusion reigns.   It may come after a spouse passes or a marriage goes off the rails.   It’s the same situation for women who never married. The questions are many.   The answers may be few.   Toward the top of the list of concerns is the issue of understanding.   Although there are always complex matters, it’s essential that all of the elements are clearly presented in a straightforward fashion.   There’s more.   Presentation is one thing, but comprehension is another. If there’s a question, it must be asked.   Clarity is the key.   Don’t just say I get it when you don’t.   And, it’s essential to grasp how each of the items fits in the overall situation. In the absence of understanding, no decisions will be made. Here are some of the most pressing questions? What’s the smart way to handle my investments? Where should I go for advice? A bank, stockbroker, attor...

Sound Advice: September 19, 2026

Is AI good news or bad news for investments? AI is potentially very good news for investors—but not automatically good news for every investment . The key distinction is between AI as an economic technology and AI stocks at today's prices . As of September 2026, there are compelling reasons for both optimism and caution: The bullish case: AI spending remains enormous. Gartner estimates global AI spending at $2.7 trillion in 2026 , up 49.5% year over year. If AI produces sustained productivity gains, corporate profits could expand well beyond the companies currently selling AI hardware. The valuation case: Investors have already priced in a lot of success. Valuations of major AI companies are elevated and expected long-term earnings growth is well above historical norms. The spending-risk case: The five largest hyperscalers are expected to spend more than $1 trillion on AI-related capital expendit...